Literature DB >> 20633746

Predictors of pain intensity and pain functioning in patients with the hepatitis C virus.

Benjamin J Morasco1, Marilyn Huckans, Jennifer M Loftis, Jonathan Woodhouse, Adriana Seelye, Dennis C Turk, Peter Hauser.   

Abstract

OBJECTIVE: To examine the relationships among biological and psychological variables with pain intensity and pain functioning in patients with the hepatitis C virus (HCV).
METHODS: Participants were 49 patients with HCV who completed well-validated assessments of pain intensity and pain functioning. Participants also completed measures of psychological functioning, and medical records were reviewed.
RESULTS: Thirty-three (67.3%) of 49 participants had a current diagnosis for a pain-related condition. Regression analyses were conducted to examine variables associated with pain intensity and pain functioning. The psychosocial variables, particularly depression severity, accounted for an additional 21% of the variance in average pain intensity (P=.002) and 33% of the variance in pain functioning (P<.001). These results remained significant even after controlling for demographic characteristics, opioid prescription status and disease-related variables.
CONCLUSION: These results provide preliminary support for the role of biological and psychological factors in the development and exacerbation of pain in HCV patients. Future studies should include a more comprehensive assessment of pain-related factors and examine their associations with additional disease-related and biological variables. Developing a better understanding of the factors associated with pain in HCV patients will help to inform future interventions for chronic pain in this patient population. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20633746      PMCID: PMC2905602          DOI: 10.1016/j.genhosppsych.2010.03.010

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  38 in total

1.  Characteristics of methadone maintenance patients with chronic pain.

Authors:  R N Jamison; J Kauffman; N P Katz
Journal:  J Pain Symptom Manage       Date:  2000-01       Impact factor: 3.612

2.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

3.  Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.

Authors:  Ashlee J Whitehead; Steven K Dobscha; Benjamin J Morasco; Samantha Ruimy; Cara Bussell; Peter Hauser
Journal:  J Pain Symptom Manage       Date:  2008-03-20       Impact factor: 3.612

Review 4.  Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review.

Authors:  Julie A Nelligan; Jennifer M Loftis; Annette M Matthews; Betsy L Zucker; Alex M Linke; Peter Hauser
Journal:  J Clin Psychiatry       Date:  2008-05       Impact factor: 4.384

Review 5.  The biopsychosocial approach to chronic pain: scientific advances and future directions.

Authors:  Robert J Gatchel; Yuan Bo Peng; Madelon L Peters; Perry N Fuchs; Dennis C Turk
Journal:  Psychol Bull       Date:  2007-07       Impact factor: 17.737

Review 6.  Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis.

Authors:  Eldon R Tunks; Joan Crook; Robin Weir
Journal:  Can J Psychiatry       Date:  2008-04       Impact factor: 4.356

Review 7.  Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review.

Authors:  Abdel Aziz M Shaheen; Robert P Myers
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

8.  A closer look at pain and hepatitis C: preliminary data from a veteran population.

Authors:  Amy K Silberbogen; E Amy Janke; Claire Hebenstreit
Journal:  J Rehabil Res Dev       Date:  2007

9.  The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

Authors:  Marilyn Huckans; Adriana Seelye; Tiffany Parcel; Lisa Mull; Jonathan Woodhouse; Danell Bjornson; Bret E Fuller; Jennifer M Loftis; Benjamin J Morasco; Anna W Sasaki; Daniel Storzbach; Peter Hauser
Journal:  J Int Neuropsychol Soc       Date:  2009-01       Impact factor: 2.892

10.  Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease.

Authors:  Sharon E Banks; Thomas R Riley; Stanley J Naides
Journal:  Dig Dis Sci       Date:  2007-03-27       Impact factor: 3.487

View more
  17 in total

1.  Risk for prescription opioid misuse among patients with a history of substance use disorder.

Authors:  Benjamin J Morasco; Dennis C Turk; Dennis M Donovan; Steven K Dobscha
Journal:  Drug Alcohol Depend       Date:  2012-07-18       Impact factor: 4.492

2.  Biopsychosocial factors associated with pain in veterans with the hepatitis C virus.

Authors:  Benjamin J Morasco; Travis I Lovejoy; Dennis C Turk; Aysha Crain; Peter Hauser; Steven K Dobscha
Journal:  J Behav Med       Date:  2013-12-14

3.  A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic.

Authors:  Nur F Önen; Ernie-Paul Barrette; Enbal Shacham; Toshibumi Taniguchi; Michael Donovan; Edgar T Overton
Journal:  Pain Pract       Date:  2011-11-22       Impact factor: 3.183

4.  Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patient.

Authors:  Jennifer M Loftis; Peter Hauser
Journal:  Dig Dis Sci       Date:  2013-10       Impact factor: 3.199

5.  Characterising the association between positive hepatitis C virus antibody and pain among people who inject drugs.

Authors:  Michelle Ng; Kanna Hayashi; Pauline Voon; Hennady P Shulha; Kora DeBeck; M-J Milloy; Lianping Ti
Journal:  Drug Alcohol Rev       Date:  2019-08-16

6.  Health related management plans improve sleep disorders of patients with chronic liver disease.

Authors:  Chunzi Liu; Hui Xie; Xin Zhang; Yanbo Yu; Xiaoning Zhang; Yanyan Sun; Lin Zhou; Beibei Su; Huaming Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

7.  Pain-related anxiety mediates the relationship between depressive symptoms and pain interference in veterans with hepatitis C.

Authors:  Melissa H Adams; Travis I Lovejoy; Dennis C Turk; Steven K Dobscha; Peter Hauser; Benjamin J Morasco
Journal:  Gen Hosp Psychiatry       Date:  2015-07-17       Impact factor: 3.238

Review 8.  Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications.

Authors:  Peter Hauser; Shira Kern
Journal:  World J Hepatol       Date:  2015-07-28

9.  Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C.

Authors:  Benjamin J R Stewart; Deborah Turnbull; Antonina A Mikocka-Walus; Hugh A J Harley; Jane M Andrews
Journal:  J Clin Psychol Med Settings       Date:  2013-12

Review 10.  Depression, fatigue and neurocognitive deficits in chronic hepatitis C.

Authors:  Sern Wei Yeoh; Alex C N Holmes; Michael M Saling; Ian P Everall; Amanda J Nicoll
Journal:  Hepatol Int       Date:  2018-06-21       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.